|
| Press Releases |
|
 |
|
| Friday, August 19, 2022 |
|
|
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY |
| Shanghai Applied Protein Technology Co., Ltd. ("APTBIO"), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently announced the completion of its Series B with hundreds of millions of CNY, which is led by Legend Capital. more info >> |
|
| Monday, August 15, 2022 |
|
|
Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully |
| On August 2, 2022, R&G Pharmastudies Co., Ltd. (stock code: 301333.SZ), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext of Shenzhen Stock Exchange. more info >> |
|
| Tuesday, August 9, 2022 |
|
|
Legend Capital Super Antibiotic Portfolio Company: Scarce Enterprise MicuRx Pharmaceuticals is Listed on the STAR Market Successfully |
| On August 5, 2022, Legend Capital portfolio company MicuRx Pharmaceuticals, a scarce enterprise in super antibiotic, was successfully listed on the STAR Market. more info >> |
|
| Monday, August 8, 2022 |
|
|
New Power to Legend Capital Carbon Neutral Investment Portfolio: Ruicycle Raises Over RMB 300 Million from Series B |
| Shenzhen Ruicycle Environmental Protection Technology Co., Ltd (also known as Hengchuang Ruineng), a battery recycling company, recently accomplished the B round of fundraising with over RMB 300 million, which is backed by Legend Capital. more info >> |
|
| Thursday, July 28, 2022 |
|
|
Led by Legend Capital, The Leading Intelligent Special Robot Company AKA Robotics Completes Series A Financing |
| Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as "AKA Robotics"), a leading intelligent special robot company, recently completed its Series A financing round, which was led by Legend Capital. more info >> |
|
| Thursday, July 21, 2022 |
|
|
Legend Capital Portfolio Company: The Global-Leading AI Medical Imaging Company Lunit Goes Public Successfully |
| On July 21st, 2022, Lunit, a leading global AI-based cancer solutions provider invested by Legend Capital, was successfully listed on the KOSDAQ market. more info >> |
|
| Thursday, July 7, 2022 |
|
|
Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB |
| Jiangsu Huili Biotechnology Co., Ltd ("Huili Bio"), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of its Series A financing round with hundreds of million RMB. more info >> |
|
| Thursday, June 16, 2022 |
|
|
Legend Capital Increases Carbon Neutrality Investments: Portfolio Company Talent New Energy Completes A++ Financing Round with Several Hundred Million RMB |
| Legend Capital's portfolio company Talent New Energy, a new Chinese powerhouse in the solid-state battery industry, recently announced the completion of its Series A++ financing round with several hundred million RMB. more info >> |
|
| Wednesday, June 15, 2022 |
|
|
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM |
| On June 14, two of Legend Capital's portfolio companies, Innovent Biologics, Inc. ("Innovent") and PT Etana Biotechnologies Indonesia ("Etana"), jointly announced that the Indonesian Food and Drugs Authority (BPOM) had approved Bevagen (bevacizumab biosimilar) more info >> |
|
| Thursday, June 9, 2022 |
|
|
Legend Capital Portfolio: Japan's No.1 VTuber Operator ANYCOLOR Lists on the Tokyo Stock Exchange |
| On June 8th 2022, Legend Capital's portfolio company ANYCOLOR, a leading Virtual YouTuber (VTuber) management company in Japan, was listed on the Tokyo Stock Exchange. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
OBIファーマとTegMine Therapeutics、糖鎖標的ADCに関する独占的グローバルライセンス契約を締結
Jan 12, 2026 21:00: JST
|
|
|
浩鼎與 TegMine Therapeutics簽訂醣標靶ADC 全球商業授權合約
Jan 12, 2026 20:00 HKT/SGT
|
|
|
浩鼎与 TegMine Therapeutics 签订醣靶标 ADC 全球商业授权合约
Jan 12, 2026 20:00 HKT/SGT
|
|
|
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Jan 12, 2026 20:00 HKT/SGT
|
|
|
查理控股（OTCQB:CHUC）與IKE科技簽署協議，將推出革命性年齡驗證電子煙產品以解決FDA對青少年接觸的擔憂
Jan 12, 2026 19:00 HKT/SGT
|
|
|
查理控股公司（OTCQB:CHUC）与IKE科技签署协议，将推出革命性年龄验证电子烟产品以解决FDA对青少年获取渠道的担忧
Jan 12, 2026 19:00 HKT/SGT
|
|
|
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access
Jan 12, 2026 19:00 HKT/SGT
|
|
|
Toys & Games Fair, Baby Products Fair and Stationery & School Supplies Fair open today
Jan 12, 2026 18:26 HKT/SGT
|
|
|
Argentine Football Association (AFA) arbeitet mit Verofax zusammen, um Fans KI-gestützte Erlebnisse zu bieten
Jan 12, 2026 16:00 HKT/SGT
|
|
|
聯想之星與君聯資本所投企業精鋒醫療在港交所成功上市
Jan 12, 2026 14:43 HKT/SGT
|
|
|
联想之星与君联资本所投企业精锋医疗在港交所成功上市
Jan 12, 2026 14:43 HKT/SGT
|
|
|
Mazda Unveils MAZDA CX-6e New Battery EV in World Premiere
Jan 12, 2026 13:10 JST
|
|
|
Argentine Football Association (AFA) se asocia con Verofax para ofrecer experiencias de IA a los aficionados
Jan 12, 2026 10:00 HKT/SGT
|
|
|
Argentine Football Association (AFA), Verofax와 협력 팬을 위한 AI 경험 제공
Jan 12, 2026 10:00 HKT/SGT
|
|
|
Argentine Football Association（AFA）攜手 Verofax 為球迷提供 AI 互動體驗
Jan 12, 2026 10:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
